1. bookVolume 24 (2016): Issue 1 (March 2016)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Acquired von Willebrand disease: from theory to practice. A single center experience - three case reports

Published Online: 19 Mar 2016
Page range: 93 - 102
Received: 20 Nov 2015
Accepted: 09 Jan 2016
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Acquired von Willebrand disease (AvWD) represents a rare, potentially severe and most likely underdiagnosed category of hemorrhagic syndromes determined by quantitative, qualitative or functional, nonhereditary, alterations of von Willebrand factor (vWF) that occur in the context of various underlying diseases. It is diagnosed mainly in adults, without any personal or familial history of bleeding. The etiopathogeny of AvWD is complex, marked by the intervention of multiple mechanisms, occuring in the evolution of neoplasia, autoimmune disorders, cardiovascular diseases and other conditions. The clinical and laboratory manifestations are similar to the congenital form with mucocutaneous hemorrhage in patients without bleeding history and demonstration of quantitative and/or functional anomalies of vWF. Treatment has two major objectives: control of bleeding and therapy of the underlying condition. As a practical illustration of the theoretical aspects we present 3 clinical cases of AvWD diagnosed in the Colţea Hospital Department of Hematology during the last 10 years.

Keywords

1. Shetty S, Kasatkar P, Ghosh K. Pathophysiology of acquired von Willebrand disease: a concise review. Eur J Haematol 2011; 87(2):99–106. DOI: 10.1111/j.1600-0609.2011.01636.x10.1111/j.1600-0609.2011.01636.xSearch in Google Scholar

2. Franchini M, Lippi G. Acquired von Willebrand syndrome: an update. Am J Hematol. 2007;82(5):368–75. DOI: 10.1002/ajh.2083010.1002/ajh.20830Search in Google Scholar

3. Mohri H. Acquired von Willebrand syndrome: Its pathophysiology, laboratory features and management. J Thromb Thrombolysis. 2003;15(3):141–9. DOI: 10.1023/B:THRO.0000011369.70824.e610.1023/B:THRO.0000011369.70824.e6Search in Google Scholar

4. Mohri H. Acquired von Willebrand syndrome: features and management. Am J Hematol. 2006;81(8):616-23. DOI: 10.1002/ajh.2045510.1002/ajh.20455Search in Google Scholar

5. Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011;117(25):6777-85. DOI: 10.1182/blood-2010-11-29758010.1182/blood-2010-11-297580Search in Google Scholar

6. Federici AB, Rand JH, Bucciarelli P, Budde U, Van Genderen PJJ, Mohri H, et al. Acquired von Willebrand syndrome: data from an International registry. Thromb Haemost. 2000;84(2):345-9.Search in Google Scholar

7. Tiede A. Diagnosis and treatment of acquired von Willebrand syndrome. Thrombosis Research. 2012;130(Suppl. 2):S2–S6. DOI: 10.1016/S0049-3848(13)70003-310.1016/S0049-3848(13)70003-3Search in Google Scholar

8. Federici AB. Budde U, Castaman G, Rand HR, Tiede A. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost. 2013;39(2):191-201. DOI: 10.1055/s-0033-133486710.1055/s-0033-133486723397553Search in Google Scholar

9. Boissier E, Darnige L, Dougados J, Arlet JB, Dupeux S, Georgin-Lavialle S, et al. Acquired von Willebrand syndrome: A case series of nine patients and literature review. Rev Med Interne. 2014;35(3):154-9. DOI: 10.1016/j.revmed.2013.02.03910.1016/j.revmed.2013.02.03923746599Search in Google Scholar

10. Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost. 2002;28(2):227-38. DOI: 10.1055/s-2002-2782410.1055/s-2002-2782411992245Search in Google Scholar

11. Federici AB, Budde U, Rand JH. Acquired von Willebrand syndrome 2004: International registry. Hamostaseologie. 2004;24(1):50–5.10.1055/s-0037-1619606Search in Google Scholar

12. Federici AB. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Semin Hematol 2006;43(1 Suppl 1):S48–58. DOI: 10.1053/j.seminhematol.2005.11.00310.1053/j.seminhematol.2005.11.00316427386Search in Google Scholar

13. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349(4):343-9. DOI: 10.1056/NEJMoa02283110.1056/NEJMoa02283112878741Search in Google Scholar

14. Fukumoto Y. Impact of acquired von Willebrand syndrome in severe aortic stenosis. J Atheroscler Thromb. 2015;22(11):1113-4. DOI: 10.5551/jat.ED02410.5551/jat.ED02426370453Search in Google Scholar

15. Tamura T, Horiuchi H, Imai M, Tada T, Shiomi H, Kuroda M, et al. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index. J Atheroscler Thromb. 2015 Nov 2;22(11):1115-23. DOI: 10.5551/jat.3080910.5551/jat.3080926269004Search in Google Scholar

16. Zoghi B, Shaughnessy P, Lyons RM, Helmer R, Bachier C, LeMaistre CF. Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG. Case Rep Hematol. 2015;2015:809313. DOI: 10.1155/2015/80931310.1155/2015/809313439896125922770Search in Google Scholar

17. Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, et al. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus. 2015;13(3):498-513.Search in Google Scholar

18. Lancelloti S, Dragani A, Ranalli P, Petrucci G, Basso M, Tartaglione R, et al. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. J Thromb Haemost. 2015;13(7):1226-37. DOI: 10.1111/jth.1296710.1111/jth.1296725876231Search in Google Scholar

19. Scrobohaci ML, Daniel MT, Levy Y, Marolleau JP, Brouet JC. Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease. Br J Haematol. 1993;84(3):471–5. DOI: 10.1111/j.1365-2141.1993.tb03103.x10.1111/j.1365-2141.1993.tb03103.x8217799Search in Google Scholar

20. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation. 2000;102(11):1290–5. DOI: 10.1161/01.CIR.102.11.129010.1161/01.CIR.102.11.129010982545Search in Google Scholar

21. Kruse-Jarres R. Acquired bleeding disorders in the elderly. Hematology Am Soc Hematol Educ Program. 2015. 2015(1):231-6. DOI: 10.1182/asheducation-2015.1.23110.1182/asheducation-2015.1.23126637727Search in Google Scholar

22. Pipe N, Goldenberg N. Acquired Disorders of Hemostasis. In Orkin SH, Fisher DE, Ginsburg D, Look TA, Lux SE, Nathan DG Eds. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood 8th Ed. Elsevier Saunders, Philadelphia. 2015:1103-24.Search in Google Scholar

23. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single centre cohort study. J Thromb Haemost. 2008;6(4):569-76. DOI: 10.1111/j.1538-7836.2008.02909.x10.1111/j.1538-7836.2008.02909.x18208537Search in Google Scholar

24. Manfredi E, van Zaane B, Gerdes V.E.A, Brandjes D.P.M, Squizzato A. Hypothyroidism and acquired von Willebrand’s syndrome: a systematic review. Haemophilia. 2008;14(3):423-33. DOI: 10.1111/j.1365-2516.2007.01642.x10.1111/j.1365-2516.2007.01642.x18218015Search in Google Scholar

25. Stuijver DJ, Piantanida E, van Zaane B, Galli L, Romualdi E, Tanda ML, et al. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. Haemophilia. 2014;20(3):326-32. DOI: 10.1111/hae.1227510.1111/hae.1227524118466Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo